The NSF Phase II grant provides funding of about $735,000 to complete the development of the noise attenuation technology, a process anticipated to be completed in 2018. Invictus states that it has assembled a set of world-renowned experts in the field of active noise attenuation to assist in this effort.
"The impact this product is going to have on the health of preterm infants in the NICU and on their cognitive development is very important," said Dennis Kane, Invictus Medical's CEO. "Invictus is committed to help this vulnerable population and we're gratified that the NSF saw the potential this represents."
About Invictus Medical
Invictus Medical is a San Antonio, Texas–based medical device company that aims to ensure that children are able to attain their developmental milestones. As evidenced by their award-winning innovations, Invictus Medical has been at the forefront of pediatric care since its founding in 2012. Invictus Medical is a privately held company. For more information about Invictus Medical, please see www.Invictusmed.com.
George Hutchinson, PhD
Logo - http://photos.prnewswire.com/prnh/20160929/413495LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/national-science-foundation-grant-to-fund-commercialization-of-new-nicu-technology-300336729.html
SOURCE Invictus Medical